ストックスクリーナーアプリを入手
0.75
5.90%
-0.05
Celularity Inc (CELU) 最新ニュース
Number of shareholders of Celularity Inc. – NASDAQ:CELUW - TradingView
Celularity Inc. Warrant 2021-16.07.26 on Celularity -A- Financial Disclosures & SEC Filings - TradingView
Celularity Inc. Announces Resignation of Vincent LeVien as Director, Effective June 26, 2026 - marketscreener.com
Celularity Inc. Enters into a Loan Agreement with the Philip & Daniele Barach Family Trust - marketscreener.com
Celularity Inc. Secures $1 Million Loan from Philip & Daniele Barach Family Trust – Form 8-K Filing Details and Key Agreement Terms 141519 - Minichart
CELULARITYSECURES $1 MLN LOAN FROM PHILIP & DANIELE BARACH FAMILY TRUSTSEC FILING - Moomoo
Celularity Secures $1 Million Bridge Loan From Barach Family Trust, Due in 30 Days or Financing - TradingView
Insider trust lends $1M to Celularity (NASDAQ: CELU) on short term - Stock Titan
Celularity Inc (NASDAQ: CELU) Share Price, CELU Stock News, CELU Share Price & Updates - Kalkine
Enterprise value to EBIT forward of Celularity Inc. – NASDAQ:CELU - TradingView
Enterprise value to EBITDA forward of Celularity Inc. – NASDAQ:CELU - TradingView
Price to sales forward of Celularity Inc. – NASDAQ:CELU - TradingView
Celularity Appoints Chief Operating Officer - Moomoo
Celularity Inc (CELU) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Celularity appoints Steven N. Gordon as COO and K. Harold Fletcher as CLO & Corporate Secretary - TradingView
New leadership at Celularity (NASDAQ: CELU) as Gordon joins board - Stock Titan
Celularity Inc. Class A Actuals & Estimates (NASDAQ:CELU) - TradingView
Form 4 Celularity Inc For: 23 June By Investing.com - Investing.com South Africa
Barach Family Trust (CELU) lets $2M note, warrant options lapse while holding large derivatives - Stock Titan
Celularity (NASDAQ: CELU) insider trust sees $2M note option expire - Stock Titan
Celularity (NASDAQ: CELU) major holder’s $2M note option and 839K warrants expire - Stock Titan
Form 13D/A Celularity Inc. For: 23 June By Investing.com - Investing.com Australia
Barach Family Trust updates 15.8% Celularity (CELU) stake in 13D/A - Stock Titan
CELU Technical Analysis & Stock Price Forecast - Intellectia AI
Penny Stocks: Why Is Celularity (CELU) Stock Trending Today? - TipRanks
Celularity Inc (CELU) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Celularity Inc (CELU) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Celularity Inc (CELU) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Celularity Inc (CELU) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Celularity Inc (CELUW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Celularity Inc (CELUW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Celularity Inc (CELUW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Celularity Inc (CELUW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Celularity Inc (CELUW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Celularity Inc (CELUW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Celularity Inc (CELUW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Celularity Inc (CELUW) Institutional Confidence - TradingKey
Celularity Inc (CELUW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Celularity Inc (CELU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Celularity Inc (CELU) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Celularity Inc (CELU) Valuation: PE, PB & Fair Value Analysis - TradingKey
Celularity Inc (CELU) Institutional Confidence - TradingKey
Celularity Inc. Warrant (CELUW) Holds at $0.01 Amid Minimal Volatility – Key Levels in FocusPCR Moving Average - newsline.com
Celularity Faces Nasdaq Listing Compliance Risk After Notice - The Globe and Mail
Celularity Inc. 8-K Filing June 2026: Nasdaq Listing, Company Details, and Securities Information - Minichart
Celularity receives Nasdaq notice for non-compliance with $35 million market value rule - Investing.com
Celularity Received Notice of Noncompliance - TradingView
[8-K] Celularity Inc Reports Material Event - Stock Titan
Celularity (CELU) Slips 6% as Stock Approaches Key Support at $0.69Price Gap Fill - newsline.com
Celularity Inc. (CELU) Slips 7.4% as Selling Pressure Continues Near Key SupportLow Volatility Picks - newsline.com
CELU - Finviz
Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies - The Manila Times
New Florida law lets doctors use placental cell therapy before FDA approval - Stock Titan
Celularity names Rick Gonzalez as chief commercial officer - Investing.com UK
Celularity: Actions Are Intended to Streamline Business and Concentrate Resources >CELU - Moomoo
Celularity refocuses on cell therapy after biomaterials sale - Investing.com
Celularity Appoints Rick Gonzalez as Chief Commercial Officer - TipRanks
1.03%
2.69%
大文字化:
|
ボリューム (24 時間):